MPL W515L is uncommon in myeloproliferative diseases but is associated with abnormal STAT5 activation similar to that seen with JAK2 V617F

被引：0
|
作者：
Schade, A. E. [1 ]
Szpurka, H. [1 ]
Bak, B. [1 ]
Maciejewski, J. P. [1 ]
Hsi, E. D. [1 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
来源：
MODERN PATHOLOGY | 2007年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1188
引用
收藏
页码：259A / 259A
页数：1
相关论文
共 50 条
  • [31] Platelet and coagulation activation in myeloproliferative diseases (MPD), and relationship to JAK2(V617F) mutation status and clonality.
    Robertson, Beverley J.
    Urquhart, Colin
    Ford, Isobel
    Watson, Henry G.
    Viekers, Mark
    Greaves, Michael
    BLOOD, 2006, 108 (11) : 100B - 100B
  • [32] Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V617F status, clonality, and antiphospholipid antibodies
    Robertson, B.
    Urquhart, C.
    Ford, I.
    Townend, J.
    Watson, H. G.
    Vickers, M. A.
    Greaves, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (08) : 1679 - 1685
  • [33] JAK2 V617F is associated with 5q-syndrome in Chinese
    Wong, K.
    Wong, W.
    Siu, L.
    Lau, T.
    Chan, N.
    CHROMOSOME RESEARCH, 2009, 17 : 114 - 114
  • [34] The V617F JAK2 mutation is uncommon in cancers and in myeloid malignancies other than the classic myeloproliferative disorders
    Scott, LM
    Campbell, PJ
    Baxter, EJ
    Todd, T
    Stephens, P
    Edkins, S
    Wooster, R
    Stratton, MR
    Futreal, PA
    Green, AR
    BLOOD, 2005, 106 (08) : 2920 - 2921
  • [35] JAK2 V617F mutation in classic chronic myeloproliferative diseases: a report on a series of 349 patients
    J L Vizmanos
    C Ormazábal
    M J Larráyoz
    N C P Cross
    M J Calasanz
    Leukemia, 2006, 20 : 534 - 535
  • [36] JAK2 V617F mutation in classic chronic myeloproliferative diseases:: a report on a series of 349 patients
    Vizmanos, JL
    Ormazábal, C
    Larráyoz, MJ
    Cross, NCP
    Calasanz, MJ
    LEUKEMIA, 2006, 20 (03) : 534 - 535
  • [37] Importance of JAK2 V617F allele burden in the diagnosis of myeloproliferative diseases and its association to age
    Rapado, Inmaculada
    Albizua, Enriqueta
    Ayala, Rosa
    Hernandez, Jose Angel
    Garcia-Alonso, Luis
    Grande, Silvia
    Gallardo, Miguel
    Gilsanz, Florinda
    Martinez-Lopez, Joaquin
    BLOOD, 2007, 110 (11) : 237B - 237B
  • [38] Validity test study of JAK2 V617F and allele burden quantification in the diagnosis of myeloproliferative diseases
    Inmaculada Rapado
    Enriqueta Albizua
    Rosa Ayala
    Jose Angel Hernández
    Luis Garcia-Alonso
    Silvia Grande
    Miguel Gallardo
    Florinda Gilsanz
    Joaquin Martinez-Lopez
    Annals of Hematology, 2008, 87 : 741 - 749
  • [39] JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5
    C Cleyrat
    J Jelinek
    F Girodon
    M Boissinot
    T Ponge
    J-L Harousseau
    J-P Issa
    S Hermouet
    Leukemia, 2010, 24 : 1069 - 1073
  • [40] JAK2 mutation and disease phenotype: a double L611V/V617F in cis mutation of JAK2 is associated with isolated erythrocytosis and increased activation of AKT and ERK1/2 rather than STAT5
    Cleyrat, C.
    Jelinek, J.
    Girodon, F.
    Boissinot, M.
    Ponge, T.
    Harousseau, J-L
    Issa, J-P
    Hermouet, S.
    LEUKEMIA, 2010, 24 (05) : 1069 - 1073
12345